Velicept Therapeutics, Inc.

Venture-backed company · Stage unknown· PA
Rounds on record
2
Latest round
Jul 12, 2018
Form D equity offering
Latest round size
$15.5M
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1

Financing history

2 rounds
  1. Jul 12, 2018
    Form D equity offering · $15.5M (form d sold)
    Valence Life Sciences, LLC via Scott David Morenstein
    Fact Form D · “Velicept Therapeutics, Inc. Form D, first filed 2018-07-18”
  2. Nov 23, 2015
    Form D equity offering · $12.0M (form d sold)
    Valence Life Sciences, LLC via Scott David Morenstein
    Fact Form D · “Velicept Therapeutics, Inc. Form D, first filed 2015-12-01”

Investors on record

2 edges

Ownership and outcomes

none on record
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

0 officers, 0 directors
No officer or director on record.

Timeline

0 events
No dated event on record.

Evidence

0 observations
Every observation on this company